Ippolito Lab

About The Ippolito Lab

Current research of the Ippolito Lab utilizes molecular and proteomic techniques for the comprehensive profiling of antibody repertoires in human adaptive immune responses. The method is a synergistic combination of (i) IgG immunoglobulin protein mass spectrometry and (ii) a high-throughput DNA sequencing method that preserves the natural pairing of B-cell heavy and light chain variable regions (VH:VL regions). This innovation allows for the direct comparison of protein-level plasma IgG immunoglobulin repertoires to DNA-level repertoires in circulating peripheral blood B cells—a unique description that is yielding fresh insights into the temporal dynamics and sequence composition of antibody-mediated immunity. These techniques have been applied to the analysis of vaccine responses, autoimmunity, cancer, and infectious diseases like COVID-19. Two key technologies, BCR-Seq and Ig-Seq, are used in concert to gather immune response data that is then subjected to bioinformatic analysis.

2023 Research

2022 Research

2021 Research

2020 Research